Literature DB >> 3069437

Treatment of dysmenorrhoea and premenstrual syndrome with non-steroidal anti-inflammatory drugs.

S S Shapiro1.   

Abstract

The menstrual cycle is associated with 2 potentially incapacitating events: dysmenorrhoea and premenstrual syndrome. Although substantial evidence has accumulated to indicate that excessive endometrial production of prostaglandin F2 alpha is the major underlying cause of painful menstruation, correspondingly little is currently known about the basic aetiology of the premenstrual syndrome. Non-steroidal anti-inflammatory drugs have been used to alleviate the discomfort of both entities, and while these agents have come to assume a primary role in the treatment of dysmenorrhoea, a body of evidence substantiating their efficacy in premenstrual syndrome has yet to be developed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3069437     DOI: 10.2165/00003495-198836040-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  100 in total

1.  Myometrial physiology and its relation to pelvic pain.

Authors:  R A WOODBURY; R TORPIN
Journal:  J Am Med Assoc       Date:  1947-07-26

2.  The myometrial response to intra-uterine administration of PGF2alpha and PGE2 in dysmenorrheic women.

Authors:  V Lundström
Journal:  Acta Obstet Gynecol Scand       Date:  1977       Impact factor: 3.636

3.  Effect of eight prostaglandins on platelet aggregation.

Authors:  N Chandra Sekhar
Journal:  J Med Chem       Date:  1970-01       Impact factor: 7.446

4.  Dysmenorrhea and its therapy: a uterine contractility study.

Authors:  W W Filler; W C Hall
Journal:  Am J Obstet Gynecol       Date:  1970-01-01       Impact factor: 8.661

5.  Endogenous prostaglandins in dysmenorrhea and the effect of prostaglandin synthetase inhibitors (PGSI) on uterine contractility.

Authors:  V Lundström; K Gréen; K Svanborg
Journal:  Acta Obstet Gynecol Scand Suppl       Date:  1979

6.  Prostaglandin synthetase inhibitors and dysmenorrhea. A survey and personal clinical experience.

Authors:  J Jacobson; K Cavalli-Björkman; V Lundström; B Nilsson; M Norbeck
Journal:  Acta Obstet Gynecol Scand Suppl       Date:  1979

7.  Diflunisal compared with naproxen in the treatment of dysmenorrhea.

Authors:  P Kajanoja; K Kauste
Journal:  Prostaglandins Leukot Med       Date:  1984-08

8.  Anaprox in dysmenorrhea: reduction of pain and intrauterine pressure.

Authors:  M R Henzl; E Ortega-Herrera; C Rodriguez; A Izu
Journal:  Am J Obstet Gynecol       Date:  1979-10-15       Impact factor: 8.661

Review 9.  Dysmenorrhoea and prostaglandins: pharmacological and therapeutic considerations.

Authors:  M Y Dawood
Journal:  Drugs       Date:  1981-07       Impact factor: 9.546

10.  Effect of ibuprofen on menstrual blood prostaglandin levels in dysmenorrheic women.

Authors:  M O Pulkkinen; A I Csapo
Journal:  Prostaglandins       Date:  1979-07
View more
  4 in total

Review 1.  Pharmacoeconomics of nonsteroidal anti-inflammatory drugs (NSAIDs).

Authors:  H A Wynne; M Campbell
Journal:  Pharmacoeconomics       Date:  1993-02       Impact factor: 4.981

2.  Prevalence and Impact of Dysmenorrhoea among Omani High School Students.

Authors:  Rahma Al-Kindi; Anbarin Al-Bulushi
Journal:  Sultan Qaboos Univ Med J       Date:  2011-10-25

3.  Mindfulness Training Intervention With the Persian Version of the Mindfulness Training Mobile App for Premenstrual Syndrome: A Randomized Controlled Trial.

Authors:  Dorsa Mazaheri Asadi; Komeil Zahedi Tajrishi; Banafsheh Gharaei
Journal:  Front Psychiatry       Date:  2022-06-17       Impact factor: 5.435

Review 4.  Over-the-counter analgesics in older adults: a call for improved labelling and consumer education.

Authors:  Christianne L Roumie; Marie R Griffin
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.